Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CD73 Is an Immunometabolic Biomarker of Poor Prognosis in Patients With Primary Cutaneous Squamous Cell Carcinoma and Hematologic Malignancy.

Autor: Saeidi V; All authors are affiliated with the Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York., Jackson Cullison SR, Doudican NA, Carucci JA, Stevenson ML

Publikováno v: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [Dermatol Surg] 2024 Jul 08. Date of Electronic Publication: 2024 Jul 08.

Self-supervised artificial intelligence predicts recurrence, metastasis and disease specific death from primary cutaneous squamous cell carcinoma at diagnosis.

Autor: Coudray N; Applied Bioinformatics Laboratories, New York University School of Medicine, New York, NY, USA.; Department of Cell Biology, New York University School of Medicine, New York, NY, USA., Juarez MC; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA., Criscito MC; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA., Quiros AC; School of Computing Science, University of Glasgow, Glasgow, Scotland, UK., Wilken R; Department of Dermatology, Northwell Health, New York, NY, USA., Cullison SRJ; Department of Dermatology, Thomas Jefferson University, Philadelphia, PA, USA., Stevenson ML; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA., Doudican NA; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA., Yuan K; School of Computing Science, University of Glasgow, Glasgow, Scotland, UK (Ke Yuan).; School of Cancer Sciences, University of Glasgow, Glasgow, Scotland, UK (Ke Yuan).; Cancer Research UK Beatson Institute, Glasgow, Scotland, UK (Ke Yuan)., Aquino JD; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA., Klufas DM; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA., North JP; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA., Yu SS; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA., Murad F; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ruiz E; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Schmults CD; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Tsirigos A; Applied Bioinformatics Laboratories, New York University School of Medicine, New York, NY, USA.; Department of Pathology, New York University School of Medicine, New York, NY, USA., Carucci JA; The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.

Publikováno v: Research square [Res Sq] 2023 Dec 13. Date of Electronic Publication: 2023 Dec 13.

Evaluating Rates of Positive Margins After Standard Excision of Cutaneous Adnexal Malignancies.

Autor: Cheraghlou S; All authors are affiliated with the Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York., Doudican NA, Criscito MC, Stevenson ML, Carucci JA

Publikováno v: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [Dermatol Surg] 2023 Oct 01; Vol. 49 (10), pp. 907-913. Date of Electronic Publication: 2023 Aug 02.